| Literature DB >> 33837878 |
Victoria Girard1, Valérie Monnin2, Delphine Giraud2, Sophie Polsinelli2, Marion Caillé2,3, Gary W Procop4, Marion Tuohy4, Deborah Wilson4, Sandra S Richter4,5, Katalin Kiss6, Kimberly Clem6, Nicholas Tolli6, Laurence Bridon7, Constance Bradford8, Sara Blamey8, Jay Li9, David H Pincus10.
Abstract
The use of matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry has proven to be rapid and accurate for the majority of clinical isolates. Some gaps remain concerning rare, emerging, or highly pathogenic species, showing the need to continuously expand the databases. In this multicenter study, we evaluated the accuracy of the VITEK MS v3.2 database in identifying 1172 unique isolates compared to identification by DNA sequence analysis. A total of 93.6% of the isolates were identified to species or group/complex level. A remaining 5.2% of the isolates were identified to the genus level. Forty tests gave a result of no identification (0.9%) and 12 tests (0.3%) gave a discordant identification compared to the reference identification. VITEK MS is also the first MALDI-TOF MS system that is able to delineate the four members of the Acinetobacter baumannii complex at species level without any specific protocol or special analysis method. These findings demonstrate that the VITEK MS v3.2 database is highly accurate for the identification of bacteria and fungi encountered in the clinical laboratory as well as emerging species like Candida auris and the highly pathogenic Brucella species.Entities:
Keywords: Brucella; Emerging pathogens; MALDI-TOF; Mass spectrometry; VITEK MS
Year: 2021 PMID: 33837878 DOI: 10.1007/s10096-021-04242-1
Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN: 0934-9723 Impact factor: 3.267